Innovation in Development of Dermatologic Drugs Approved by the US Food and Drug Administration Between 2012 and 2022.

ABSTRACT:

SUBMITTER: Kamat S 

PROVIDER: S-EPMC10733849 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature